Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells

7Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cancer-testicular Antigens (CTAs) belong to a group of proteins that under normal conditions are strictly expressed in a male’s reproductive tissues. However, upon malignisation, they are frequently re-expressed in neoplastic tissues of various origin. A number of studies have shown that different CTAs affect growth, migration and invasion of tumor cells and favor cancer development and metastasis. Two members of the CTA group, Semenogelin 1 and 2 (SEMG1 and SEMG2, or SEMGs) represent the major component of human seminal fluid. They regulate the motility and capacitation of sperm. They are often re-expressed in different malignancies including breast cancer. However, there is almost no information about the functional properties of SEMGs in cancer cells. In this review, we highlight the role of SEMGs in the reproductive system and also summarize the data on their expression and functions in malignant cells of various origins.

Cite

CITATION STYLE

APA

Shuvalov, O., Kizenko, A., Petukhov, A., Fedorova, O., Daks, A., & Barlev, N. (2021, June 1). Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells. Cell Death Discovery. Springer Nature. https://doi.org/10.1038/s41420-021-00482-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free